CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for RBC Bioscience Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

RBC Bioscience Corp
15F
No.15, Qiaohe Road, Zhonghe District
Phone: +886 289121200p:+886 289121200 NEW TAIPEI, 235  Taiwan Ticker: 68486848
Business Summary
RBC Bioscience Corp is a Taiwan-based medical device manufacturer that provides manufacture and sale services for nucleic acid purification automation equipment and nucleic acid purification reagents. The company's products are mainly divided into instruments and reagents. The instruments are equipped with ultraviolet sterilization system to improve the quality of nucleic acid purification, and the disposable individual reagent strips and tips can be used with different built-in control programs to achieve different types of nucleic acid extraction. The company developed and produced a variety of nucleic acid purification reagents with cellulose-embedded magnetic beads, which can improve the purity of nucleic acid, and therefore can be used to purify deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) for blood, bacteria, viruses and forensic examinations for future diagnosis, prevention, tracking, treatment of diseases or identification.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes----

Industries
SIC Code Description
3826 Laboratory analytical instruments
2836 Biological products, except diagnostic substances
2835 In vitro and in vivo diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager MingweiZhuo
Deputy General Manager-Management Division KexinZhan 9/16/2021 9/16/2021
Deputy General Manager-Manufacturing Division JunyongZhuo 5/23/2023 5/23/2023
5 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 12,975,600 (As of 6/30/2024)
Stock Exchange: TPO
Fax Number: +886 289121300


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024